Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Absorption and Transit of TREXIMA vs RELPAX in Migraine
NCT00385008Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2006
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sumatriptan + naproxen sodium in migraine (2 arms), sponsored by GSK. Primary endpoints: Time to 10%, 50%, 90% and Complete Gastric Empting at Day 1, Area Under the Drug Concentration Time Curve and 5 more. Started Sep 2006; status: completed.
02
Drugs
sumatriptan + naproxen sodium
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00385008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385008.